Clinical Features and Treatment Outcomes among Children with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A 20-Year Study in a Tertiary Referral Hospital

Table 5

Treatment outcomes according to supportive care alone versus systemic treatment.

	Supportive care only, N = 8	Systemic treatment, N = 28	P value
Length of hospital stay (d) (mean ± SD)	9.9 ± 7.4	12.3 ± 11.4	0.593
Comorbidities/short-term complication, N (%)
Skin
Dyspigmentation	5 (62.5)	21 (75.0)	0.486
Nail change	0	4 (14.3)	0.257
Eye	5 (62.5)	19 (67.9)	0.777
Conjunctivitis	3 (37.5)	14 (50.0)	0.532
Corneal epithelial defects	2 (25.0)	4 (14.3)	0.473
Synechiae/symblepharon	2 (25.0)	4 (14.3)	0.608
Pseudomembrane	1 (12.5)	5 (17.9)	0.720
Superinfection	1 (12.5)	9 (32.1)	0.532
Vaginal adhesion	1 (12.5)	2 (7.1)	0.629
Pneumonia	1 (12.5)	1 (3.6)	0.331
Pancreatitis	0	1 (3.6)	0.588
Adrenal insufficiency	0	1 (3.6)	0.588
Long-term sequel, N (%)
Skin	4 (50.0)	15 (53.6)	0.261
Eye	5 (62.5)	8 (28.6)	0.302
GI (transaminitis)	2 (25.0)	6 (21.4)	0.795
Recurrence, N (%)	0	1 (3.6)	0.588